FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1565637071> ?p ?o ?g. }

• W1565637071 endingPage "34" @default.
• W1565637071 startingPage "19" @default.
• W1565637071 abstract "Deprivation of estrogen causes breast tumors in women to adapt and develop enhanced sensitivity to this steroid. Accordingly, women relapsing after treatment with oophorectomy, which substantially lowers estradiol for a prolonged period, respond secondarily to aromatase inhibitors with tumor regression. We have utilized in vitro and in vivo model systems to examine the biologic processes whereby Long Term Estradiol Deprivation (LTED) causes cells to adapts and develop hypersensitivity to estradiol. Several mechanisms are associated with this response including up-regulation of ERα and the MAP kinase, PI-3-kinase and mTOR growth factor pathways. ERα is 4–10 fold up-regulated as a result of demethylation of its C promoter, This nuclear receptor then co-opts a classical growth factor pathway using SHC, Grb-2 and Sos. This induces rapid nongenomic effects which are enhanced in LTED cells. The molecules involved in the nongenomic signaling process have been identified. Estradiol binds to cell membrance-associated ERα which physically associates with the adaptor protein SHC and induces its phosphorylation. In turn, SHC binds Grb-2 and Sos which results in the rapid activation of MAP kinase. These nongenomic effects of estradiol produce biologic effects as evidenced by Elk-1 activation and by morphologic changes in cell membrances. Additional effects include activation of the PI-3-kinase and mTOR pathways through estradiol-induced binding of ERα to the IGF-1 and EGF receptors. A major question is how ERα locates in the plasma membrance since it does not contain an inherent membrance localization signal. We have provided evidence that the IGF-1 receptor serves as an anchor for ERα in the plasma membrane. Estradiol causes phosphorylation of the adaptor protein, SHC and the IGF-1 receptor itself. SHC, after binding to ERα, serves as the “glue” which tethers ERα to SHC binding sites on the activated IFG-1 receptors. Use of siRNA methodology to knock down SHC allows the conclusion that SHC is needed for ERα to localize in the plasma membrane. In order to abrogate growth factor induced hypersensitivity, we have utilized a drug, farnesylthiosalicylic acid, which blocks the binding of GTP-Ras to its membrance acceptor protein, galectin 1 and reduces the activation of MAP kinase. We have shown that this drug is a potent inhibitor of mTOR and this provides the major means for inhibition of cell proliferation. The concept of “adaptive hypersensitivity” and the mechanisms responsible for this phenomenon have important clinical implications. The efficacy of aromatase inhibitors in patients relapsing on tamoxifen could be explained by this mechanism and inhibitors of growth factor pathways should reverse the hypersensitivity phenomenon and result in prolongation of the efficacy of hormonal therapy for breast cancer." @default.
• W1565637071 created "2016-06-24" @default.
• W1565637071 creator A5005302720 @default.
• W1565637071 creator A5015803537 @default.
• W1565637071 creator A5024202469 @default.
• W1565637071 creator A5032679769 @default.
• W1565637071 creator A5032896185 @default.
• W1565637071 creator A5048768673 @default.
• W1565637071 creator A5081817848 @default.
• W1565637071 creator A5083264718 @default.
• W1565637071 creator A5084033038 @default.
• W1565637071 date "2008-01-01" @default.
• W1565637071 modified "2023-09-29" @default.
• W1565637071 title "Adaptation to Estradiol Deprivation Causes Up-Regulation of Growth Factor Pathways and Hypersensitivity to Estradiol in Breast Cancer Cells" @default.
• W1565637071 cites W143639218 @default.
• W1565637071 cites W1602106987 @default.
• W1565637071 cites W1662062786 @default.
• W1565637071 cites W1975960976 @default.
• W1565637071 cites W1985046165 @default.
• W1565637071 cites W1988385815 @default.
• W1565637071 cites W1988626741 @default.
• W1565637071 cites W2004271648 @default.
• W1565637071 cites W2024654932 @default.
• W1565637071 cites W2026976628 @default.
• W1565637071 cites W2029489419 @default.
• W1565637071 cites W2039321134 @default.
• W1565637071 cites W2041144670 @default.
• W1565637071 cites W2045792003 @default.
• W1565637071 cites W2049761405 @default.
• W1565637071 cites W2052190886 @default.
• W1565637071 cites W2058903258 @default.
• W1565637071 cites W2065917789 @default.
• W1565637071 cites W2079252365 @default.
• W1565637071 cites W2083117834 @default.
• W1565637071 cites W2086407765 @default.
• W1565637071 cites W2090407808 @default.
• W1565637071 cites W2090576400 @default.
• W1565637071 cites W2104795646 @default.
• W1565637071 cites W2107180907 @default.
• W1565637071 cites W2108326951 @default.
• W1565637071 cites W2114712559 @default.
• W1565637071 cites W2117565990 @default.
• W1565637071 cites W2154112585 @default.
• W1565637071 cites W2154808997 @default.
• W1565637071 cites W2157001620 @default.
• W1565637071 cites W4210952142 @default.
• W1565637071 cites W4232034161 @default.
• W1565637071 cites W4233675981 @default.
• W1565637071 cites W4237514360 @default.
• W1565637071 cites W4250537252 @default.
• W1565637071 cites W4252951100 @default.
• W1565637071 doi "https://doi.org/10.1007/978-0-387-78818-0_2" @default.
• W1565637071 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2641021" @default.
• W1565637071 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18637482" @default.
• W1565637071 hasPublicationYear "2008" @default.
• W1565637071 type Work @default.
• W1565637071 sameAs 1565637071 @default.
• W1565637071 citedByCount "56" @default.
• W1565637071 countsByYear W15656370712012 @default.
• W1565637071 countsByYear W15656370712013 @default.
• W1565637071 countsByYear W15656370712014 @default.
• W1565637071 countsByYear W15656370712015 @default.
• W1565637071 countsByYear W15656370712016 @default.
• W1565637071 countsByYear W15656370712017 @default.
• W1565637071 countsByYear W15656370712018 @default.
• W1565637071 countsByYear W15656370712019 @default.
• W1565637071 countsByYear W15656370712020 @default.
• W1565637071 countsByYear W15656370712021 @default.
• W1565637071 countsByYear W15656370712022 @default.
• W1565637071 countsByYear W15656370712023 @default.
• W1565637071 crossrefType "book-chapter" @default.
• W1565637071 hasAuthorship W1565637071A5005302720 @default.
• W1565637071 hasAuthorship W1565637071A5015803537 @default.
• W1565637071 hasAuthorship W1565637071A5024202469 @default.
• W1565637071 hasAuthorship W1565637071A5032679769 @default.
• W1565637071 hasAuthorship W1565637071A5032896185 @default.
• W1565637071 hasAuthorship W1565637071A5048768673 @default.
• W1565637071 hasAuthorship W1565637071A5081817848 @default.
• W1565637071 hasAuthorship W1565637071A5083264718 @default.
• W1565637071 hasAuthorship W1565637071A5084033038 @default.
• W1565637071 hasBestOaLocation W15656370712 @default.
• W1565637071 hasConcept C121608353 @default.
• W1565637071 hasConcept C126322002 @default.
• W1565637071 hasConcept C134018914 @default.
• W1565637071 hasConcept C184235292 @default.
• W1565637071 hasConcept C185592680 @default.
• W1565637071 hasConcept C2776166826 @default.
• W1565637071 hasConcept C2777164284 @default.
• W1565637071 hasConcept C502942594 @default.
• W1565637071 hasConcept C530470458 @default.
• W1565637071 hasConcept C62478195 @default.
• W1565637071 hasConcept C71924100 @default.
• W1565637071 hasConcept C84606932 @default.
• W1565637071 hasConcept C86554907 @default.
• W1565637071 hasConcept C86803240 @default.
• W1565637071 hasConcept C95444343 @default.
• W1565637071 hasConceptScore W1565637071C121608353 @default.
• W1565637071 hasConceptScore W1565637071C126322002 @default.

• next